Story thread · 2 reports / 2 sources
STAT+: ARPA-H funds biotechs working on custom RNA therapies
statnews.com · 12d
Roche licenses a tri-specific antibody, new Trump deals may undercut its own goals, and other biotech news
First report: ARPA-H awards $125M for manufacturing custom RNA therapies on demand — endpts.com, 13d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.